|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08225 C HEALTH GP
Nominal 
0.162 0.000 (0.000%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 21,620 | 18.187% | 26,454 | 21,425 | 13,090 | 83,601 |
| Cost of Sales | -- | -- | (16,387) | (13,213) | (7,347) | (19,744) |
| Gross Profit | -- | -- | 10,067 | 8,212 | 5,743 | 63,857 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | (381) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | 18 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 10,234 | 18.298% | (14,473) | (58,211) | (15,826) | 42,521 | |
| Taxation | (1,535) | 18.259% | (46) | 0 | 0 | (6,196) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 197 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 8,699 | 18.305% | (14,519) | (58,014) | (15,826) | 36,325 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (4) | -- | (63) | (116) | (185) | (415) |
| Depreciation & Amortisation | -- | -- | 606 | 234 | 151 | 201 |
| Directors' Emoluments | -- | -- | 151 | 755 | 1,156 | 260 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Qualified | Qualified | Qualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 0.870 | 17.568% | -1.460 | -5.830 | -1.590 | 3.650 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.010 | 0.001 | (0.005) | (0.010) |
| NBV per share ($) | 0.079 | -- | 0.071 | 0.085 | 0.143 | 0.156 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 8,699 |
| %Change | 18.305% |
| EPS / (LPS) | RMB 0.009 |
| NBV Per Share (¥) | RMB 0.079 |